Clinical Outcomes and Women’s Experiences before and after the Introduction of Mifepristone into Second-Trimester Medical Abortion Services in South Africa

• Deborah Constant ,

  * E-mail: Deborah.constant@uct.ac.za

  Affiliations Women’s Health Research Unit, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa, Division of Epidemiology & Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa

  http://orcid.org/0000-0002-7176-9963

  ⨯
• Jane Harries,

  Affiliation Women’s Health Research Unit, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa

  ⨯
• Thokozile Malaba,

  Affiliations Women’s Health Research Unit, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa, Division of Epidemiology & Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa

  ⨯
• Landon Myer,

  Affiliation Division of Epidemiology & Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa

  ⨯
• Malika Patel,

  Affiliation Department of Obstetrics & Gynaecology, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa

  ⨯
• Gregory Petro,

  Affiliation Department of Obstetrics & Gynaecology, University of Cape Town and New Somerset Hospital, Cape Town, South Africa

  ⨯
• Daniel Grossman

  Current address: Advancing New Standards in Reproductive Health (ANSIRH), Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, Oakland, California, United States of America

  Affiliation Ibis Reproductive Health, Oakland, California, United States of America

  ⨯